scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1010869152 |
P356 | DOI | 10.1186/1472-6750-13-2 |
P3181 | OpenCitations bibliographic resource ID | 1995030 |
P932 | PMC publication ID | 3598649 |
P698 | PubMed publication ID | 23311978 |
P50 | author | Nathan Baker | Q28318462 |
P2093 | author name string | Dennis G Thomas | |
Elaine T Freund | |||
Grace A Stafford | |||
Juli D Klemm | |||
Sue Pan | |||
Stacey L Harper | |||
Martin Fritts | |||
Sharon Gaheen | |||
David Paik | |||
Fred Klaessig | |||
Elizabeth Hahn-Dantona | |||
P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
Informatics and standards for nanomedicine technology | Q23912034 | ||
Chemical Entities of Biological Interest: an update | Q24644887 | ||
A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGE-TAB | Q24673513 | ||
Design and implementation of microarray gene expression markup language (MAGE-ML) | Q24803717 | ||
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data | Q27860569 | ||
The BioPAX community standard for pathway data sharing | Q27987775 | ||
Toward interoperable bioscience data | Q28090939 | ||
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models | Q28212902 | ||
Annotating the structure and components of a nanoparticle formulation using computable string expressions | Q28395833 | ||
The caBIG® Life Science Business Architecture Model | Q28740454 | ||
ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level | Q28749402 | ||
GenePattern 2.0 | Q29614171 | ||
Creating the gene ontology resource: design and implementation | Q29614366 | ||
ArrayExpress--a public database of microarray experiments and gene expression profiles | Q33264889 | ||
Nanotechnology: convergence with modern biology and medicine | Q34212582 | ||
Foundational biomedical informatics research in the clinical and translational science era: a call to action | Q34399770 | ||
NanoParticle Ontology for cancer nanotechnology research | Q34587815 | ||
Implementation of GenePattern within the Stanford Microarray Database. | Q37202682 | ||
Has the revolution arrived? | Q37403289 | ||
Research agenda. Opportunities for research and NIH. | Q37665780 | ||
NCI Thesaurus: a semantic model integrating cancer-related clinical and molecular information | Q38406992 | ||
The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". | Q47340613 | ||
What drives public acceptance of nanotechnology? | Q47432805 | ||
Cyberinfrastructure and the Biomedical Sciences | Q57410273 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | nanotechnology | Q11468 |
data sharing | Q5227350 | ||
nanomaterial | Q967847 | ||
P304 | page(s) | 2 | |
P577 | publication date | 2013-01-14 | |
P1433 | published in | BMC Biotechnology | Q15753225 |
P1476 | title | ISA-TAB-Nano: a specification for sharing nanomaterial research data in spreadsheet-based format | |
P478 | volume | 13 |
Q27942681 | An ISA-TAB-Nano based data collection framework to support data-driven modelling of nanotoxicology |
Q31160067 | An Integrated Data-Driven Strategy for Safe-by-Design Nanoparticles: The FP7 MODERN Project |
Q29227417 | Assessing the Exposome with External Measures: Commentary on the State of the Science and Research Recommendations |
Q39059539 | Association rule mining of cellular responses induced by metal and metal oxide nanoparticles |
Q28549191 | Cancer Biology, Toxicology and Alternative Methods Development Go Hand-in-Hand |
Q38974875 | Case Study III: The Construction of a Nanotoxicity Database - The MOD-ENP-TOX Experience. |
Q31160070 | Compilation of Data and Modelling of Nanoparticle Interactions and Toxicity in the NanoPUZZLES Project |
Q95318831 | Construction of a web-based nanomaterial database by big data curation and modeling friendly nanostructure annotations |
Q30885444 | Current situation on the availability of nanostructure-biological activity data |
Q38109493 | Developmental Neurotoxicity of Engineered Nanomaterials: Identifying Research Needs to Support Human Health Risk Assessment |
Q35794701 | Experiences in supporting the structured collection of cancer nanotechnology data using caNanoLab |
Q91152066 | Fifteen years of nanoEHS research advances science and fosters a vibrant community |
Q27908490 | How should the completeness and quality of curated nanomaterial data be evaluated? |
Q38610791 | Improvements to the APBS biomolecular solvation software suite |
Q43066944 | Integration among databases and data sets to support productive nanotechnology: challenges and recommendations |
Q38974889 | Literature Review of (Q)SAR Modelling of Nanomaterial Toxicity |
Q57274162 | Minimum information reporting in bio-nano experimental literature |
Q26852294 | Nano-Synthetic Devices in Leishmaniasis: A Bioinformatics Approach |
Q28389224 | Nanocuration workflows: Establishing best practices for identifying, inputting, and sharing data to inform decisions on nanomaterials |
Q23921579 | Nanoinformatics workshop report: current resources, community needs and the proposal of a collaborative framework for data sharing and information integration |
Q27008517 | Nanoinformatics: emerging databases and available tools |
Q34986389 | On the reproducibility of science: unique identification of research resources in the biomedical literature |
Q47639565 | Perspectives from the NanoSafety Modelling Cluster on the validation criteria for (Q)SAR models used in nanotechnology |
Q28222668 | QSAR modeling: where have you been? Where are you going to? |
Q89674196 | Quality of physicochemical data on nanomaterials: an assessment of data completeness and variability |
Q50057829 | Reproducibility, sharing and progress in nanomaterial databases |
Q23911115 | The Nanomaterial Data Curation Initiative: a collaborative approach to assessing, evaluating, and advancing the state of the field |
Q28551680 | The Ontology for Biomedical Investigations |
Q24188395 | The eNanoMapper database for nanomaterial safety information |
Q27701165 | The first eNanoMapper prototype: A substance database to support safe-by-design |
Q39210459 | Transparent stakeholder engagement in practice: Lessons learned from applying comprehensive environmental assessment to research planning for nanomaterials |
Q49932047 | What incentives increase data sharing in health and medical research? A systematic review |
Q30866817 | caNanoLab: data sharing to expedite the use of nanotechnology in biomedicine |
Q27062683 | eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment |
Search more.